Bianca Perfler

Graz, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in mice.

Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in mice.

Journal: Science translational medicine

Published: November 26, 2025

A Novel Potent and Selective GCN2 Inhibitor, APL-4098, Has Antileukemic Activity through Dysregulation of Mitochondrial Function.

A Novel Potent and Selective GCN2 Inhibitor, APL-4098, Has Antileukemic Activity through Dysregulation of Mitochondrial Function.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 19, 2025

Limited Alleviation of Lysosomal Acid Lipase Deficiency by Deletion of Matrix Metalloproteinase 12.

Limited Alleviation of Lysosomal Acid Lipase Deficiency by Deletion of Matrix Metalloproteinase 12.

Journal: International journal of molecular sciences

Published: August 29, 2024

miR-23a mediates resistance to hypomethylating agents in myeloid neoplasms.

miR-23a mediates resistance to hypomethylating agents in myeloid neoplasms.

Journal: Annals of hematology

Published: June 21, 2021

EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity.

EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity.

Journal: Leukemia

Published: August 17, 2020

Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia.

Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia.

Journal: Clinical epigenetics

Published: June 03, 2020

Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia.

Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia.

Journal: Cancers

Published: January 28, 2020

Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis.

Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis.

Journal: Haematologica

Published: October 21, 2018

Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration.

Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration.

Journal: Blood

Published: January 04, 2018

Showing 1-9 of 9

Last Updated: 09/26/2026